Immuneering Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Zeskind Benjamin J. | President and CEO | Purchase | 2,098 | $15.00 | $31,470 | 2,600,269 | Aug 3, 2021 |
| KEATING LAURIE | — | Purchase | 7,000 | $15.00 | $105,000 | 7,000 | Aug 3, 2021 |
| Hall Brett Matthew | Chief Scientific Officer | C | 5,040 | — | — | 5,040 | Aug 3, 2021 |
| CARPENTER ROBERT J | — | Purchase | 325,000 | $15.00 | $4,875,000 | 1,148,839 | Aug 3, 2021 |
| Bookman Michael | General Counsel and Secretary | Purchase | 1,402 | $15.00 | $21,030 | 1,402 | Aug 3, 2021 |
| BERMAN ANN E | — | Purchase | 3,500 | $15.00 | $52,500 | 3,500 | Aug 3, 2021 |
| Barrett Scott | Chief Medical Officer | C | 5,996 | — | — | 5,996 | Aug 3, 2021 |
| Amin Biren | CFO, Treasurer | C | 2,723 | — | — | 2,723 | Aug 3, 2021 |